Med. praxi. 2016;13(5):e1-e8 | DOI: 10.36290/med.2016.059
Classical multiple sclerosis treatment comprise beta-interferon, glatiramer-acetate and natalizumab, which can effectively modify
the natural course of the disease. Recently new treatment options are avilable, including drugs with better eficacy and oral way
of administration, where better compliance can be predicted. The aim of this review is to advice physicians in everyday praxis of
drug safety of specific medicaments treating multiple sclerosis.
Published: December 1, 2016 Show citation